Zentek Ltd. (ZTEK)
NASDAQ: ZTEK · Real-Time Price · USD
1.170
0.00 (0.00%)
Mar 27, 2025, 4:00 PM EDT - Market closed

Company Description

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada.

The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.

The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021.

Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

Zentek Ltd.
Zentek logo
Country Canada
Founded 2008
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 24
CEO Gregory Fenton

Contact Details

Address:
24 Corporate Court
Guelph, ON N1G 5G5
Canada
Phone 844-730-9822
Website zentek.com

Stock Details

Ticker Symbol ZTEK
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency CAD
CIK Code 0001904501
CUSIP Number 98942X102
ISIN Number CA98942X1024
SIC Code 2890

Key Executives

Name Position
Gregory Fenton C.F.A. Chief Executive Officer and Director
Wendy Ford CA, CPA Chief Financial Officer
Dr. Colin van der Kuur B.Sc., DMIN Chief Science Officer
Ryan Shacklock Senior Vice President of Strategy and Business Development

Latest SEC Filings

Date Type Title
Mar 21, 2025 6-K Report of foreign issuer
Mar 12, 2025 6-K Report of foreign issuer
Mar 4, 2025 6-K Report of foreign issuer
Mar 4, 2025 6-K Report of foreign issuer
Mar 3, 2025 424B5 Filing
Feb 28, 2025 6-K/A Filing
Feb 28, 2025 6-K/A Filing
Feb 14, 2025 6-K Report of foreign issuer
Feb 13, 2025 6-K Report of foreign issuer
Jan 17, 2025 6-K Report of foreign issuer